• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

45株彭氏变形杆菌临床分离株的药敏情况。

Susceptibilities of 45 clinical isolates of Proteus penneri.

作者信息

Fuksa M, Krajden S, Lee A

出版信息

Antimicrob Agents Chemother. 1984 Sep;26(3):419-20. doi: 10.1128/AAC.26.3.419.

DOI:10.1128/AAC.26.3.419
PMID:6508270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176184/
Abstract

Patterns of susceptibility of 45 Proteus penneri clinical isolates to 14 antimicrobial agents were evaluated by a macrobroth dilution method. All strains were highly susceptible to ceftizoxime, ceftazidime, moxalactam, cefoxitin, gentamicin, tobramycin, netilmicin, and, with few exceptions, to amikacin, piperacillin, and cefoperazone. Most strains were susceptible to cefotaxime and ceftriaxone. All strains were resistant to cefazolin and cefsulodin.

摘要

采用常量肉汤稀释法评估了45株彭氏变形杆菌临床分离株对14种抗菌药物的敏感性模式。所有菌株对头孢唑肟、头孢他啶、拉氧头孢、头孢西丁、庆大霉素、妥布霉素、奈替米星高度敏感,除少数例外,对阿米卡星、哌拉西林和头孢哌酮也高度敏感。大多数菌株对头孢噻肟和头孢曲松敏感。所有菌株对头孢唑林和头孢磺啶耐药。

相似文献

1
Susceptibilities of 45 clinical isolates of Proteus penneri.45株彭氏变形杆菌临床分离株的药敏情况。
Antimicrob Agents Chemother. 1984 Sep;26(3):419-20. doi: 10.1128/AAC.26.3.419.
2
Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents.少动假单胞菌对24种抗菌药物的敏感性
Antimicrob Agents Chemother. 1983 Jan;23(1):161-2. doi: 10.1128/AAC.23.1.161.
3
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.氨基糖苷类药物与β-内酰胺类药物联合用于抗革兰氏阴性菌。体外协同作用及化学相互作用的评估。
Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0.
4
[Urinary tract infections and microbiological characteristics of Proteus penneri isolated in Taiwan].
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1987 May;20(2):132-9.
5
Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.变形杆菌属细菌对六种头孢菌素和三种氨基糖苷类抗生素敏感性的种间差异。
Antimicrob Agents Chemother. 1982 Aug;22(2):218-21. doi: 10.1128/AAC.22.2.218.
6
In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.头孢他啶对需氧革兰氏阴性杆菌及脆弱拟杆菌群的体外研究。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:83-9. doi: 10.1093/jac/8.suppl_b.83.
7
Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.氨曲南、其他β-内酰胺类抗生素及氨基糖苷类抗生素对铜绿假单胞菌的体外活性比较
Chemioterapia. 1984 Aug;3(4):258-61.
8
[Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].[摩根菌-变形杆菌-普罗威登斯菌属细菌临床分离株的抗菌药敏性]
Jpn J Antibiot. 1991 Feb;44(2):140-9.
9
Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.40株铜绿假单胞菌对10种抗假单胞菌抗菌药物的敏感性比较。
Isr J Med Sci. 1982 Aug;18(8):859-62.
10
In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.头孢他啶与其他九种抗菌药物对革兰氏阴性医院菌株的体外比较。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:53-6. doi: 10.1093/jac/8.suppl_b.53.

引用本文的文献

1
Potential virulence factors of Proteus bacilli.变形杆菌属细菌的潜在毒力因子。
Microbiol Mol Biol Rev. 1997 Mar;61(1):65-89. doi: 10.1128/mmbr.61.1.65-89.1997.
2
Analysis of antibiotic resistance determinants in Proteus penneri.彭氏变形杆菌抗生素耐药决定因素分析
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):467-9. doi: 10.1007/BF01967445.
3
Expanded clinical spectrum of infections caused by Proteus penneri.彭氏变形杆菌引起感染的临床谱扩大。
J Clin Microbiol. 1987 Mar;25(3):578-9. doi: 10.1128/jcm.25.3.578-579.1987.
4
Urease activity of Proteus penneri.彭氏变形杆菌的脲酶活性
J Clin Microbiol. 1987 Dec;25(12):2302-5. doi: 10.1128/jcm.25.12.2302-2305.1987.
5
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估,以及关于其治疗用途的最新情况,特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.
6
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
7
Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host.彭氏变形杆菌在中性粒细胞减少宿主中引起的菌血症和皮下脓肿。
J Clin Microbiol. 1990 Jul;28(7):1645-6. doi: 10.1128/jcm.28.7.1645-1646.1990.

本文引用的文献

1
Comparative activities of 13 beta-lactam antibiotics.13种β-内酰胺类抗生素的比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):925-34. doi: 10.1128/AAC.21.6.925.
2
Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1.彭氏变形杆菌新种的鉴定,该菌以前被称为吲哚阴性普通变形杆菌或普通变形杆菌生物群1。
J Clin Microbiol. 1982 Jun;15(6):1097-102. doi: 10.1128/jcm.15.6.1097-1102.1982.
3
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.头孢替坦,一种新型头孢霉素:与其他头孢菌素的体外抗菌活性比较、β-内酰胺酶稳定性及纸片扩散法检测的初步建议
Antimicrob Agents Chemother. 1982 Nov;22(5):859-77. doi: 10.1128/AAC.22.5.859.
4
In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.新型半合成头孢霉素抗生素T-1982的体外和体内抗菌活性
Antimicrob Agents Chemother. 1982 Nov;22(5):728-34. doi: 10.1128/AAC.22.5.728.
5
Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.与其他广谱头孢菌素相比,SM-1652的抗菌活性。
Antimicrob Agents Chemother. 1982 Nov;22(5):721-7. doi: 10.1128/AAC.22.5.721.
6
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.替莫西林(BRL 17421)的体外活性,一种新型的β-内酰胺酶稳定青霉素。
Antimicrob Agents Chemother. 1982 Jul;22(1):157-61. doi: 10.1128/AAC.22.1.157.
7
Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.新型碳青霉烯类抗生素卡培霉素A和B的抗菌及β-内酰胺酶抑制活性
Antimicrob Agents Chemother. 1982 Apr;21(4):536-44. doi: 10.1128/AAC.21.4.536.
8
In vitro activity of azthreonam, a monobactam antibiotic.单环β-内酰胺类抗生素氨曲南的体外活性
Antimicrob Agents Chemother. 1982 Nov;22(5):832-8. doi: 10.1128/AAC.22.5.832.
9
Comparative in vitro activity of semisynthetic penicillins against Proteeae.半合成青霉素对变形杆菌属的体外活性比较
Antimicrob Agents Chemother. 1983 Apr;23(4):619-21. doi: 10.1128/AAC.23.4.619.
10
Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.变形杆菌属细菌对六种头孢菌素和三种氨基糖苷类抗生素敏感性的种间差异。
Antimicrob Agents Chemother. 1982 Aug;22(2):218-21. doi: 10.1128/AAC.22.2.218.